Skip to content
Movie Casting Call
Author:
Innovative Molecules GmbH
Innovative Molecules Announces First Patient Dosed in Phase 2a Trial of Adibelivir (IM-250), Advancing Company into Late-Stage Clinical Development
June 25, 2026
Innovative Molecules Expands Virology Pipeline with Novel EBV Antiviral Program
June 16, 2026